Author Archives: Catarina Silva, MSc

Approval of Off-the-Shelf Stem Cell Therapy to Treat Epidermolysis Bullosa Sought in Japan, JCR Pharmaceuticals Says

JCR Pharmaceuticals is asking regulators in Japan to extend the use of Temcell HS Injection to epidermolysis bullosa (EB) patients in that country as a wound healing treatment. Temcell HS is a mesenchymal stem cell therapy that approved to treat acute graft versus host disease (aGVHD), a severe complication of allogeneic (donor-derived) bone…